Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study

被引：0

作者：

John P. Haran

Jose C. Pinero

Yan Zheng

Norma Alonzo Palma

Mark Wingertzahn

机构：

[1] University of Massachusetts Medical School,Department of Emergency Medicine, Department of Microbiology and Physiological Systems, Clinical Director of the Center for Microbiome Research

[2] UMass Memorial Medical Group,undefined

[3] Hope Clinical Trials,undefined

[4] Kaleido Biosciences,undefined

[5] Inc,undefined

来源：

Trials | / 22卷

关键词：

COVID-19; randomised controlled study; protocol; KB109; microbiome; short-chain fatty acids;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用